Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!
39results about Morphinans companies
See how new Discovery Search works for you
Find the fast-growing companyGrowth Fast to Slow
Sort by:
Most relevant
Most relevant
Growth Fast to Slow
Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS.
Purdue Pharma L.P. is a privately held pharmaceutical company owned principally by descendants of Mortimer and Raymond Sackler. In 2007, it paid out one of the largest fines ever levied against a pharmaceutical firm for mislabeling its product OxyContin, and three executives were found guilty of criminal charges. Although the company shifted its focus to abuse-deterrent formulations, Purdue continued to market and sell opioids, and continued to be involved in lawsuits around the opioid epidemic in the United States. Purdue filed for Chapter 11 bankruptcy protection on September 15, 2019 in New York.
Phoenix PharmaLabs believes strongly in the value to the worldwide human family of a class of potent analgesics with the potential to relieve pain and suffering without the problems of addiction, side effects and death.
The Company believes that superior shareholder and investor return can be accomplished while delivering relief to millions of pain sufferers and opiate addicts.
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid-induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin).
TaiwanJ Pharmaceuticals Co., Ltd. engages in new medical research activities. It offers drug testing, biotechnology services, and sale of western medicine. The company was founded by Sen Chou Wu on May 2, 2011 and is headquartered in Hsinchu, Taiwan.
F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Alkermes Pharma Ireland Ltd., part of Alkermes Plc, is a company headquartered in Athlone, Ireland. The firm develops and manufactures oral dosage products.
C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.
Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA.
Sun Pharmaceutical Industries (Australia) Pty Ltd., part of Sun Pharmaceutical Industries Ltd., is a company headquartered in Notting Hill, Australia. The firm wholesales drugs.
Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.
AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.
Boehringer Ingelheim KG, part of C.H. Boehringer Sohn AG & Co. KG, is a company headquartered in Biberach, Germany. The firm wholesales pharmaceutical products. It was founded in 1981.
Willow Biosciences, Inc. is a biotechnology company, which engages in the research, development, and commercialization of plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. It operates through the Canada and The Rest of the World, and Unites States geographical segments. The company was founded on April 15, 1981 and is headquartered in Calgary, Canada.
Alpharma (Bermuda) Investments Ltd., part of Zoetis, Inc., is a Bermudian company. The firm provides investment services.
More
BioLinc
1962
|
Canada
|
-
|
http://www.brocku.ca/biolinc
|
Private Company
The Goodman School of Business BioLinc is part of Innovate Niagara’s network of incubators. BioLinc is a dynamic bioscience, biotechnology, applied health and biomanufacturing business incubation facility dedicated to promote, enhance, and commercialize the discoveries that are taking place at Brock, while bringing Niagara’s health, bioscience, and biomanufacturing sectors to the next level.
Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP
Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.